Cargando…
Co-administering Melatonin With an Estradiol-Progesterone Menopausal Hormone Therapy Represses Mammary Cancer Development in a Mouse Model of HER2-Positive Breast Cancer
Melatonin has numerous anti-cancer properties reported to influence cancer initiation, promotion, and metastasis. With the need for effective hormone therapies (HT) to treat menopausal symptoms without increasing breast cancer risk, co-administration of nocturnal melatonin with a natural, low-dose H...
Autores principales: | Dodda, Balasunder R., Bondi, Corry D., Hasan, Mahmud, Clafshenkel, William P., Gallagher, Katie M., Kotlarczyk, Mary P., Sethi, Shalini, Buszko, Ethan, Latimer, Jean J., Cline, J. Mark, Witt-Enderby, Paula A., Davis, Vicki L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636553/ https://www.ncbi.nlm.nih.gov/pubmed/31355130 http://dx.doi.org/10.3389/fonc.2019.00525 |
Ejemplares similares
-
Morinda citrifolia (Noni) Juice Augments Mammary Gland Differentiation and Reduces Mammary Tumor Growth in Mice Expressing the Unactivated c-erbB2 Transgene
por: Clafshenkel, William P., et al.
Publicado: (2012) -
Novel Melatonin, Estrogen, and Progesterone Hormone Therapy Demonstrates Anti-Cancer Actions in MCF-7 and MDA-MB-231 Breast Cancer Cells
por: Hasan, Mahmud, et al.
Publicado: (2020) -
Melatonin Patterns and Levels During the Human Menstrual Cycle and After Menopause
por: Greendale, Gail A, et al.
Publicado: (2020) -
Pharmacokinetics of the first combination 17β-estradiol/progesterone capsule in clinical development for menopausal hormone therapy
por: Pickar, James H., et al.
Publicado: (2015) -
Sarcopenia and Menopause: The Role of Estradiol
por: Geraci, Annalisa, et al.
Publicado: (2021)